About: Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 22 August 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) im Januar 2018 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована у 2018 (uk) article scientifique publié en 2018 (fr) artículu científicu espublizáu n'agostu de 2018 (ast) scientific article published on 22 August 2018 (en)
publication date	wds:Q58724543-D2859A9D-ACBE-4C5D-972F-67E9C3ABBD52
publication date	2018-08-22 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58724543-FBA29A8C-067C-4FBE-88D5-06AFF1D61027
language of work or name	English
exact match	wds:Q58724543-C6AFF4DA-B7D2-4295-820B-6EC0BE1CD0FF
exact match	https://scigraph.springernature.com/pub.10.1186/s12935-018-0609-9
cites work	wds:Q58724543-00891881-67EB-4B72-BB30-A2AAA28EEAF0 wds:Q58724543-12EA49E6-4A9A-417C-9C8A-858FC1034D37 wds:Q58724543-1908F05A-9635-4FFD-828E-CD0E0B79782B wds:Q58724543-1AD13D0C-0B9D-4E33-83D4-2D11FF234C87 wds:Q58724543-1D8E2CA5-3844-4DEC-A38B-C95ED0100963 wds:Q58724543-205CD6E2-0EB1-44A2-AF20-566FBEB0FF55 wds:Q58724543-2CB170C0-0E7B-456C-8E97-FEDB5F1A4221 wds:Q58724543-336D5C91-3D32-43BF-BF7E-140425205D26 wds:Q58724543-3A0C1482-2AF1-4F9A-A9D2-85D8AE9B6E25 wds:Q58724543-620C08FD-1353-4A16-9942-7392FD9D6ED0 wds:Q58724543-66369DF0-6CD0-4A79-8367-E524224461FB wds:Q58724543-66EB230D-09F6-4F50-AE69-CCDE1C42C2CB wds:Q58724543-6D0A2828-614C-4C60-8E79-089B561F4665 wds:Q58724543-79CD784C-2481-4AC9-B45F-04436E8E3915 wds:Q58724543-820C8683-731B-4AD6-ACA5-8E0FFC14C519 wds:Q58724543-8725A42B-5431-4F57-8A09-CB67C0A76545 wds:Q58724543-8E599BF1-F6BB-4C3C-8E68-5295923AA8CE wds:Q58724543-92586B48-3829-47F1-A55F-161626383ED6 wds:Q58724543-A391B447-7B19-47BC-AA61-50317C062A24 wds:Q58724543-A5662349-2692-4D65-ADEB-A8B60719B15D wds:Q58724543-AF5F391F-667A-4A5D-B2CC-1346FDCB52E3 wds:Q58724543-D23E3927-B618-452A-874E-A8C72DBDFDA4 wds:Q58724543-D2D00CE5-4D4D-467E-99DE-7BB9E0CEAB3D wds:Q58724543-D697B095-F6F1-4CF8-9B5C-A499DDF44E73 wds:Q58724543-DAD001EC-4E17-47A7-858D-94431E3C7498 wds:Q58724543-E58DDDE1-BC3E-4B28-8B11-87075FF07C1C wds:Q58724543-E5CE5292-802F-43BD-989C-313DCEF9459D wds:Q58724543-EEBC8990-A118-478F-9FFB-293210BA729A wds:Q58724543-F16626C8-B176-4F08-9A95-3EB95B4A8E00 wds:Q58724543-F68778CB-B000-41CA-A298-57D79D0E1579 wds:Q58724543-F82CB0BA-E09E-44F1-A5EC-472C1844ACC4 wds:Q58724543-FA23C5DA-F31E-4AE9-9F35-330C7A4E544D wds:Q58724543-FC29FB12-D5EF-4C71-BC6F-7C03318D4838 wds:Q58724543-FEFE5468-E6B0-47B3-8251-EE2500CF8141
cites work	Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now? Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. Dose-response analyses using restricted cubic spline functions in public health research Relapsed/refractory diffuse large B-cell lymphoma Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system Cancer-related inflammation Improving outcomes for patients with diffuse large B-cell lymphoma New strategies in diffuse large B-cell lymphoma: translating findings from gene expression analyses into clinical practice Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas metaSEM: an R package for meta-analysis using structural equation modeling Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era. C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients. Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI. The role of inflammation in lymphoma. Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era. Serum lactate dehydrogenase with a systemic inflammation score is useful for predicting response and survival in patients with newly diagnosed diffuse large B-cell lymphoma Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphoma Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone [Value of Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio for Prognostic Evaluation of Diffuse Large B-cell Lymphoma] Prognostic role of pretreatment neutrophil-lymphocyte ratio in patients with diffuse large B-cell lymphoma treated with RCHOP.
author name string	wds:Q58724543-0FE314C8-93AB-41A4-9130-3FCF1B27C38A wds:Q58724543-36F01E87-5C1D-48D1-A51E-8CFA21A43A22 wds:Q58724543-382783B0-F500-4C75-BB3F-6E72FEBC9E3D wds:Q58724543-8022D74F-D5BF-4BE4-B9A2-40804A8773B5 wds:Q58724543-E2734892-E696-4D78-989F-B409D40FB063
author name string	Chunyan Sun You Qin Fengjuan Fan Lisha Ai Shidai Mu
rdfs:label	Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis (en) Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis (nl)
skos:prefLabel	Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis (en) Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis (nl)
name	Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis (en) Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis (nl)
author	wds:Q58724543-BE00D18A-BDAC-46C0-99A7-5116C882ED08
author	Yu Hu
title	wds:Q58724543-08D2A7C6-7915-4BE4-BDC4-3F5231DB1757

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software